Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, et al. SCOPE 2021: a new scorecard
for osteoporosis in Europe. Arch Osteoporos. 2021; 2; 16(1): 82.
Kanis JA, on behalf of the World Health Organization Scientific Group. Assessment of Osteoporosis at the Primary Health-Care Level. Technical Report. WHO Collaborating Centre for Metabolic Bone Diseases. University of Sheffield, Sheffield, UK. World Health Organization. Summary Report of a WHO Scientific Group. WHO, Geneva.www.who.int/chp/topics/rheumatic/en/index.html
Díez Pérez A. El debate sobre el FRAX. Rev Osteoporos Metab Miner. 2010; 2: 5-6.
Claus–Hermberg H, Bagur A, Messina OD, Negri A L, Schurmann L, Sanchez A. FRAX, un nuevo instrumento para calcular el riesgo absoluto de fracturas a 10 años. Medicina (Buenos Aires). 2009; 69:571-5.
del Río L, Tebe, C, Johansson H, Gregorio S, Estrada S, Espallargues M. Aplicación del método de evaluación del riesgo absoluto de fractura (FRAX) en población española. Rev Mult Gerontol. 2009; 19(Supl. 1): 17.
González Macías J, Marín M, Vila J, Díez Pérez A, Abizanda M, Alvarez R, et al. Prevalencia de factores de riesgo de osteoporosis y fracturas osteoporóticas en una serie de 5.195 mujeres mayores de 65 años. Med Clin (Barc). 2004; 123(3): 85-9.
McGrother CW, Donaldson MMK, Clayton D, Abrams KR, Clarke M. Evaluation of a hip fracture risk store for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study. Osteoporos Int. 2002; 13: 89-96.
DOI: 10.1007/s198-002-8343-6
O'Neill TW, Cooper C, Algra D, Pols HAP, Agnusdei D, Dequeker J, on behalf of the European Vertebral Osteoporosis Study Group. Design and development of a questionnaire for use in a multicentre study of vertebral osteoporosis in Europe: The European vertebral osteoporosis study (EVOS). Rheumatology in Europe. 1995; 24:75‐81.
O'Neill TW, Cooper C, Cannata JB, Diaz Lopez JB, Hoszowski K, Johnell O, et al. Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: the European Vertebral Osteoporosis Study. Int J Epidemiol. 1994; 23: 559‐65.
DOI: 10.1093/ije/23.3.559
Naves M, Rodriguez-Garcia M, Diaz-Lopez JB, Gomez-Alonso C, Cannata-Andia JB. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int. 2008; 19(8):1161-6.
DOI: 10.1007/s00198-007-0539-1
Azagra Ledesma R, Prieto Alhambra D, Encabo Duró G, Casado Burgos E,
Aguyé Batista E, Díaz Pérez A, en representación del grupo de estudio FRIDEX. Utilidad de la herramienta FRAX en el tratamiento de la osteoporosis en población femenina española. Med Clin (Barc). 2011; 136(14): 613–9.
DOI: 10.1016/j.medcli.2010.09.043
Naves M, Díaz López JB, Gómez C, Rodríguez Rebollar A, Cannata Andía JB. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50. Osteoporos Int. 2005; 16(12): 2013-7.
DOI: 10.1007/s00198-005-1983-4
Azagra R, Roca G, Martín Sánchez JC, Casado E, Encabo G, Zwart M, et al. Umbrales de FRAX para identificar personas con alto o bajo riesgo de fractura osteoporótica en población femenina española. Med Clin (Barc). 2015; 144(1): 1-8.
DOI: 10.1016/j.medcli.2013.11.014
Minaković I, Zvekić-Svorcan J, Janković T, Vuksanović M, Mikić D, Bošković K. Early menopause and risk of fractures–A preventable gap. Iran J Public Health, 2023; 52 (3): 534-41
DOI: 10.18502/ijph.v52i3.12136
Perez Cano R, Galan Galan F, Dilsen G. Risk factors for hip fracture in Spanish and Turkish women. Bone. 1993; 14 (Suppl 1): S69-72.
DOI: 10.1016/8756-3282(93)90353-C
Wang Q, Huang Q, Zeng Y, Liang JJ, Liu SY, Gu X, et al. Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies. Osteoporos Int. 2016; 27(1): 319-30.
DOI: 10.1007/s00198-015-3351-3
Sullivan SD, Lehman A, Nathan NK, Thomson CA, Howardet BV. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination. Menopause. 2017; 24 (4): 371-8.
DOI: 10.1097/GME.0000000000000775
Anagnostis P, Siolos P, Gkekas NK, Kosmidou N, Artzouchaltzi AM, Christou K, et al. Association between age at menopause and fracture risk: a systematic review and meta-analysis. Endocrine. 2019; 63 (2): 213-24.
DOI: 10.1007/s12020-018-1746-6
Yoo JE, Shin DW, Han K, Kim D, Yoon JW, Lee DY. Association of female reproductive factors with incidence of fracture among postmenopausal women in Korea. JAMA Netw Open. 2021; 4(1): e2030405.
DOI: 10.1001/jamanetworkopen.2020.30405
Rodríguez-García M, Gómez-Alonso C, Rodríguez-Rebollar A, Palomo-Antequera C, Martín-Vírgala J, Martín-Carro B, Fernández-Villabrille S, Rodríguez-Carrio J, Cannata-Andía JB, Naves-Díaz M. Efecto de la fragilidad y la sarcopenia sobre el riesgo de caídas y de fracturas osteoporóticas en población no seleccionada.Rev Osteoporos Metab Miner. 2020;12(3):81-86.
DOI: 10.4321/S1889-836X2020000300002